Jaya Krishnan
Imperial College London, UK
Biography
Jaya Krishnan received his BSc (Hons.) and PhD from Imperial College London. He performed his Post-doctoral studies at the ETH-Zurich, Switzerland and currently leads an RNA Therapeutics group at the Centre for Molecular Medicine, Goethe-University Frankfurt, Germany. He is the Co-founder and CTO of Targeted Transgenesis, a premier Bio-therapeutics company focused on delivering tissue targeted therapeutics and transgenesis for pre-clinical and clinical studies. He has published in prestigious journals including Nature, Cell Metabolism, Blood and Circulation Research and serves as a reviewer for major Governmental, Non-profit and Charitable grant agencies and for numerous academic journals.
Abstract
Abstract : HERNA1 antisense RNA inhibition reverses cardiac pathology and improves survival